Home/Filings/4/0001104659-25-062092
4//SEC Filing

Schneeberger Daniel 4

Accession 0001104659-25-062092

CIK 0001664710other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 4:05 PM ET

Size

21.8 KB

Accession

0001104659-25-062092

Insider Transaction Report

Form 4
Period: 2025-06-20
Transactions
  • Exercise of In-Money

    Common Stock

    2025-06-20$70.00/sh1,400$98,0004,391,237 total(indirect: By ADAR1 Partners, LP)
  • Exercise of In-Money

    Common Stock

    2025-06-20$70.00/sh200$14,000743,358 total(indirect: By LLC)
  • Exercise of In-Money

    Put Option (right to sell)

    2025-06-2010 total(indirect: By ADAR1 Partners, LP)
    Exercise: $60.00From: 2024-10-02Exp: 2025-06-20Common Stock (100 underlying)
  • Exercise of In-Money

    Put Option (right to sell)

    2025-06-20140 total(indirect: By ADAR1 Partners, LP)
    Exercise: $70.00From: 2024-10-01Exp: 2025-06-20Common Stock (1,400 underlying)
  • Exercise of In-Money

    Put Option (right to sell)

    2025-06-2020 total(indirect: By LLC)
    Exercise: $70.00From: 2024-10-01Exp: 2025-06-20Common Stock (200 underlying)
  • Exercise of In-Money

    Common Stock

    2025-06-20$60.00/sh100$6,0004,392,637 total(indirect: By ADAR1 Partners, LP)
Transactions
  • Exercise of In-Money

    Common Stock

    2025-06-20$70.00/sh200$14,000743,358 total(indirect: By LLC)
  • Exercise of In-Money

    Put Option (right to sell)

    2025-06-2010 total(indirect: By ADAR1 Partners, LP)
    Exercise: $60.00From: 2024-10-02Exp: 2025-06-20Common Stock (100 underlying)
  • Exercise of In-Money

    Put Option (right to sell)

    2025-06-20140 total(indirect: By ADAR1 Partners, LP)
    Exercise: $70.00From: 2024-10-01Exp: 2025-06-20Common Stock (1,400 underlying)
  • Exercise of In-Money

    Put Option (right to sell)

    2025-06-2020 total(indirect: By LLC)
    Exercise: $70.00From: 2024-10-01Exp: 2025-06-20Common Stock (200 underlying)
  • Exercise of In-Money

    Common Stock

    2025-06-20$60.00/sh100$6,0004,392,637 total(indirect: By ADAR1 Partners, LP)
  • Exercise of In-Money

    Common Stock

    2025-06-20$70.00/sh1,400$98,0004,391,237 total(indirect: By ADAR1 Partners, LP)
Transactions
  • Exercise of In-Money

    Common Stock

    2025-06-20$60.00/sh100$6,0004,392,637 total(indirect: By ADAR1 Partners, LP)
  • Exercise of In-Money

    Common Stock

    2025-06-20$70.00/sh1,400$98,0004,391,237 total(indirect: By ADAR1 Partners, LP)
  • Exercise of In-Money

    Common Stock

    2025-06-20$70.00/sh200$14,000743,358 total(indirect: By LLC)
  • Exercise of In-Money

    Put Option (right to sell)

    2025-06-2010 total(indirect: By ADAR1 Partners, LP)
    Exercise: $60.00From: 2024-10-02Exp: 2025-06-20Common Stock (100 underlying)
  • Exercise of In-Money

    Put Option (right to sell)

    2025-06-2020 total(indirect: By LLC)
    Exercise: $70.00From: 2024-10-01Exp: 2025-06-20Common Stock (200 underlying)
  • Exercise of In-Money

    Put Option (right to sell)

    2025-06-20140 total(indirect: By ADAR1 Partners, LP)
    Exercise: $70.00From: 2024-10-01Exp: 2025-06-20Common Stock (1,400 underlying)
Transactions
  • Exercise of In-Money

    Common Stock

    2025-06-20$70.00/sh1,400$98,0004,391,237 total(indirect: By ADAR1 Partners, LP)
  • Exercise of In-Money

    Put Option (right to sell)

    2025-06-20140 total(indirect: By ADAR1 Partners, LP)
    Exercise: $70.00From: 2024-10-01Exp: 2025-06-20Common Stock (1,400 underlying)
  • Exercise of In-Money

    Common Stock

    2025-06-20$60.00/sh100$6,0004,392,637 total(indirect: By ADAR1 Partners, LP)
  • Exercise of In-Money

    Common Stock

    2025-06-20$70.00/sh200$14,000743,358 total(indirect: By LLC)
  • Exercise of In-Money

    Put Option (right to sell)

    2025-06-2020 total(indirect: By LLC)
    Exercise: $70.00From: 2024-10-01Exp: 2025-06-20Common Stock (200 underlying)
  • Exercise of In-Money

    Put Option (right to sell)

    2025-06-2010 total(indirect: By ADAR1 Partners, LP)
    Exercise: $60.00From: 2024-10-02Exp: 2025-06-20Common Stock (100 underlying)
Footnotes (2)
  • [F1]As the investment manager of ADAR1 Partners, LP and as the sub-advisor of Spearhead Insurance Solutions IDF, LLC, ADAR1 Capital Management, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP and Spearhead Insurance Solutions IDF, LLC. As the general partner of ADAR1 Partners, LP, ADAR1 Capital Management GP, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP. As the manager of ADAR1 Capital Management, LLC and ADAR1 Capital Management GP, LLC, Mr. Schneeberger may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP and Spearhead Insurance Solutions IDF, LLC.
  • [F2]For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Issuer

Keros Therapeutics, Inc.

CIK 0001664710

Entity typeother

Related Parties

1
  • filerCIK 0001861120

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:05 PM ET
Size
21.8 KB